REG - Hargreaves Lansdown - Directorate Change

Hargreaves LansdownAnnouncement

29/11/2023 07:15

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20231129:nRSc9795Ua&default-theme=true

RNS Number : 9795U  Hargreaves Lansdown PLC  29 November 2023

HARGREAVES LANSDOWN PLC (HL):  CHAIR SUCCESSION

 

29 November 2023

 

The Board of HL is pleased to announce the appointment of  Alison Platt to
the role of Chair of the Board and as a Non-Executive Director of HL, subject
to customary regulatory approvals.

 

Alison will succeed Deanna Oppenheimer, who will be stepping down from her
role as Chair of the Board and a Director of HL at HL's Annual General Meeting
(AGM) on 8 December 2023. She will have served as Chair for six years.

 

Alison is currently Chair of Dechra Pharmaceuticals plc (Dechra), a specialist
veterinary products business which is currently going through an acquisition
by EQT. She is also a Non-Executive Director of Tesco plc and the Chair of
general insurer, Ageas UK. Alison will join HL's Board in early 2024.

 

Alison was Chair of L&G Financial Advice from 2019 to 2022 and CEO of
Countrywide from 2014 to 2018. Prior to that she held several senior roles at
BUPA, both in the UK and Internationally.

 

Following the AGM, during the period to Alison's regulatory approval as new
permanent Chair, the Board has confirmed the appointment of Penny James
as Interim Chair. She is currently the Senior Independent Director (SID).

 

Penny will be replaced in this position by Andrea Blance as SID. These
appointments are effective from 8 December 2023 and on the appointment of the
new permanent Chair, each will revert to their prior Board position. Penny
James will chair the HL 2023 AGM.

 

Having remained on the Board to support with the Chair selection process,
Roger Perkin has informed the Board that he will also not be standing for
re-election at the AGM and will be stepping down from the HL plc Board on 8
December 2023. Roger has also served on the Board for six years, including as
Chair of the Board Audit Committee.

 

As the Company's Notice of the AGM 2023 (the Notice) has already been issued,
the Company confirms that the resolution to re-elect Deanna Oppenheimer as a
Director of the Company (Resolution 7 of the Notice) is now withdrawn. The
resolution to re-elect Roger Perkin as a Director of the Company (Resolution
10 of the Notice) is now withdrawn. The withdrawal of Resolution 7 and
Resolution 10 does not otherwise affect the validity of the Notice, the proxy
form or any proxy votes already submitted on other resolutions. The numbering
of all other proposed resolutions at the Annual General Meeting will remain
unchanged. Any votes already cast in relation to Resolution 7 and Resolution
10 are of no effect.

 

Alison Platt said:

 

"I am delighted to be joining the HL Board and excited by the opportunity to
work with Dan and the team as HL continues its critical work in supporting
clients to make savings and investment decisions with confidence. I look
forward to working closely with my new Board colleagues to guide HL's next
phase of growth."

 

 

Deanna Oppenheimer, Non-Executive Chair, HL plc, said:

 

"I'm honoured to have overseen the Board during a period of significant change
for the industry and for HL. HL is in a strong position for growth and has
skilled leadership which will ensure the company's future success. Over the
last six years our client numbers have doubled to 1.8 million and our share of
the direct-to-consumer market has grown significantly from 35% to 42%.

 

"I'm delighted to hand over to Alison, whose broad and relevant experience
across different sectors will be of great benefit and support to the HL team
as they move forward. I would also like to thank Roger for his service and
dedication to HL and for staying on over these last few months to support the
Chair selection process."

 

Dan Olley, Chief Executive Officer said:

 

"I would like to thank Deanna for her guidance and stewardship during her
tenure as Chair. I look forward to working with Alison who brings a wealth of
experience to the Board."

 

Alison's appointment follows a comprehensive recruitment process supported by
an external executive search firm. She will join and chair the Nomination
& Governance Committee of the HL plc Board upon her appointment as
Non-Executive Director, subject to regulatory approval.

 

Other than the directorships disclosed above, there are no matters required by
paragraphs LR 9.6.13R (1) to (6) of the listing rules to be disclosed.

 

 

  For further information please contact:
 Hargreaves Lansdown              Brunswick
 James Found, Investor Relations  Nick Cosgrove

 07970 066 634                    +44(0)207 404 5959
 Danny Cox, Media Relations

 07989 672 071

 

 

BIOGRAPHY

 

Alison Platt

Alison has extensive leadership experience across both private and listed
companies in the healthcare, financial services, retail and property, and
regulated sectors. She currently holds Chair positions at Dechra
Pharmaceuticals, a FTSE100 specialist veterinary products business, and
insurance company Ageas UK. She has also been a Non-Executive Director of
Tesco Plc since 2016.

 

Alison was CEO of Countrywide from 2014 - 2018 and prior to that she held
several senior roles at BUPA, including as Managing Director of its
International Development Markets business.  She was previously a
Non-executive director of the Foreign and Commonwealth Office, a member of
Hampton-Alexander review steering group advising on diversity and inclusion
and Chair of Opportunity Now.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  BOAZZMZMZRRGFZZ